CORD-19:02d18b4f484a0420c21595a95b8765125d4a484c / 33180-33382 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T192","span":{"begin":0,"end":202},"obj":"Sentence"}],"text":"Importantly, treatment with catalytically active, but not enzymatically inactive, recombinant ACE2 protein improved the symptoms of acute lung injury in wild type mice as well as in ace2 knockout mice ."}

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T192","span":{"begin":0,"end":202},"obj":"Sentence"},{"id":"TextSentencer_T192","span":{"begin":0,"end":202},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Importantly, treatment with catalytically active, but not enzymatically inactive, recombinant ACE2 protein improved the symptoms of acute lung injury in wild type mice as well as in ace2 knockout mice ."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T161","span":{"begin":132,"end":149},"obj":"Disease"},{"id":"T163","span":{"begin":143,"end":149},"obj":"Disease"}],"attributes":[{"id":"A161","pred":"mondo_id","subj":"T161","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A162","pred":"mondo_id","subj":"T161","obj":"http://purl.obolibrary.org/obo/MONDO_0015796"},{"id":"A163","pred":"mondo_id","subj":"T163","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"}],"text":"Importantly, treatment with catalytically active, but not enzymatically inactive, recombinant ACE2 protein improved the symptoms of acute lung injury in wild type mice as well as in ace2 knockout mice ."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T113","span":{"begin":138,"end":142},"obj":"Body_part"}],"attributes":[{"id":"A113","pred":"uberon_id","subj":"T113","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"Importantly, treatment with catalytically active, but not enzymatically inactive, recombinant ACE2 protein improved the symptoms of acute lung injury in wild type mice as well as in ace2 knockout mice ."}